ACRV

Chione Ltd

Known title: 10% OwnerCIK: 0001590232

Chione Ltd's purchase track record

Chione Ltd has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
11/17/2022ACRV$5.00M+46.3%-16.0%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Acrivon Therapeutics noted among health‑care stocks moving in after‑market. Acrivon Therapeutics (ACRV) was included in a Benzinga roundup of twelve health‑care stocks that showed price movement during Wednesday’s after‑market session. The mention signals recent trading activity after regular hours. The stock is currently near its 52‑week low and its RSI is below 40, suggesting limited momentum.

this person other insiders at ACRV

Transaction History

ACRV▼ Sell$207
ACRV▼ Sell$25K
ACRV▼ Sell$11K
ACRV▼ Sell$37K
ACRV▼ Sell$25K
ACRV▲ Buy$5.0M
ACRV▼ Sell—
ACRV▼ Sell—

We use analytics to understand how market-wall is used. No personal data is sold.